{"id":"https://openalex.org/W4404356876","doi":"https://doi.org/10.1016/j.xphs.2024.10.055","title":"Biowaiver monographs for immediate-release solid oral dosage forms: Voriconazole","display_name":"Biowaiver monographs for immediate-release solid oral dosage forms: Voriconazole","alternate_titles":[],"publication_year":2024,"publication_date":"2024-11-14","ids":{"openalex":"https://openalex.org/W4404356876","doi":"https://doi.org/10.1016/j.xphs.2024.10.055","pmid":"https://pubmed.ncbi.nlm.nih.gov/39547650"},"language":"en","primary_location":{"id":"doi:10.1016/j.xphs.2024.10.055","doi":"https://doi.org/10.1016/j.xphs.2024.10.055","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.xphs.2024.10.055","pdf_url":"https://jpharmsci.org/article/S0022-3549(24)00504-5/pdf","source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4404356876"],"child_works_count":0,"type":"review","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://jpharmsci.org/article/S0022-3549(24)00504-5/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5088461044","display_name":"Kristian Beran","orcid":"https://orcid.org/0000-0001-7918-0865","observed_orcids":["https://orcid.org/0000-0001-7918-0865"]},"institutions":[{"id":"https://openalex.org/I4210107844","display_name":"Fraunhofer Institute for Translational Medicine and Pharmacology","ror":"https://ror.org/01s1h3j07","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210107844","https://openalex.org/I4923324"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Kristian Beran","raw_affiliation_strings":["Fraunhofer Institute for Translational Medicine and Pharmacology, Frankfurt am Main, Germany"],"raw_orcid":"https://orcid.org/0000-0001-7918-0865","affiliations":[{"raw_affiliation_string":"Fraunhofer Institute for Translational Medicine and Pharmacology, Frankfurt am Main, Germany","institution_ids":["https://openalex.org/I4210107844"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041894017","display_name":"Bertil Abrahamsson","orcid":"https://orcid.org/0000-0003-4490-7491","observed_orcids":["https://orcid.org/0000-0003-4490-7491"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Bertil Abrahamsson","raw_affiliation_strings":["Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca Gothenburg, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oral Product Development, Pharmaceutical Technology & Development, Operations, AstraZeneca Gothenburg, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028319878","display_name":"Naseem Ahmad Charoo","orcid":"https://orcid.org/0000-0002-2519-1179","observed_orcids":["https://orcid.org/0000-0002-2519-1179"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Naseem Charoo","raw_affiliation_strings":["Aramed, 216-laboratory complex, Dubai Science Park, UAE"],"raw_orcid":"https://orcid.org/0000-0002-2519-1179","affiliations":[{"raw_affiliation_string":"Aramed, 216-laboratory complex, Dubai Science Park, UAE","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073938156","display_name":"Rodrigo Cristofoletti","orcid":"https://orcid.org/0000-0003-2619-0343","observed_orcids":["https://orcid.org/0000-0003-2619-0343"]},"institutions":[{"id":"https://openalex.org/I33213144","display_name":"University of Florida","ror":"https://ror.org/02y3ad647","country_code":"US","type":"education","lineage":["https://openalex.org/I33213144"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Rodrigo Cristofoletti","raw_affiliation_strings":["Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, FL 32827, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Center for Pharmacometrics and Systems Pharmacology, Department of Pharmaceutics, College of Pharmacy, University of Florida, Orlando, FL 32827, USA","institution_ids":["https://openalex.org/I33213144"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066208508","display_name":"Ren\u00e9 Holm","orcid":"https://orcid.org/0000-0003-4894-7765","observed_orcids":["https://orcid.org/0000-0003-4894-7765"]},"institutions":[{"id":"https://openalex.org/I177969490","display_name":"University of Southern Denmark","ror":"https://ror.org/03yrrjy16","country_code":"DK","type":"education","lineage":["https://openalex.org/I177969490"]}],"countries":["DK"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ren\u00e9 Holm","raw_affiliation_strings":["University of Southern Denmark, Department of Physics, Chemistry and Pharmacy, Odense, Denmark"],"raw_orcid":"https://orcid.org/0000-0003-4894-7765","affiliations":[{"raw_affiliation_string":"University of Southern Denmark, Department of Physics, Chemistry and Pharmacy, Odense, Denmark","institution_ids":["https://openalex.org/I177969490"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088088408","display_name":"Atsushi Kambayashi","orcid":"https://orcid.org/0000-0002-2957-6287","observed_orcids":["https://orcid.org/0000-0002-2957-6287"]},"institutions":[{"id":"https://openalex.org/I161296585","display_name":"Tokyo University of Science","ror":"https://ror.org/05sj3n476","country_code":"JP","type":"education","lineage":["https://openalex.org/I161296585"]}],"countries":["JP"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Atsushi Kambayashi","raw_affiliation_strings":["Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan"],"raw_orcid":"https://orcid.org/0000-0002-2957-6287","affiliations":[{"raw_affiliation_string":"Faculty of Pharmaceutical Sciences, Tokyo University of Science, Noda, Japan","institution_ids":["https://openalex.org/I161296585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007186343","display_name":"Peter Langguth","orcid":"https://orcid.org/0000-0003-3758-7581","observed_orcids":["https://orcid.org/0000-0003-3758-7581"]},"institutions":[{"id":"https://openalex.org/I197323543","display_name":"Johannes Gutenberg University Mainz","ror":"https://ror.org/023b0x485","country_code":"DE","type":"education","lineage":["https://openalex.org/I197323543"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Peter Langguth","raw_affiliation_strings":["Institute of Pharmacy, Johannes Gutenberg University, Mainz, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institute of Pharmacy, Johannes Gutenberg University, Mainz, Germany","institution_ids":["https://openalex.org/I197323543"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072932855","display_name":"Alan F. Parr","orcid":"https://orcid.org/0000-0002-6875-3899","observed_orcids":["https://orcid.org/0000-0002-6875-3899"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alan Parr","raw_affiliation_strings":["BioCeutics LLC, Acworth, GA 30101, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"BioCeutics LLC, Acworth, GA 30101, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073615016","display_name":"James E. Polli","orcid":"https://orcid.org/0000-0002-5274-4314","observed_orcids":["https://orcid.org/0000-0002-5274-4314"]},"institutions":[{"id":"https://openalex.org/I126744593","display_name":"University of Maryland, Baltimore","ror":"https://ror.org/04rq5mt64","country_code":"US","type":"education","lineage":["https://openalex.org/I126744593"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"James E. Polli","raw_affiliation_strings":["Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 20742, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Sciences, School of Pharmacy, University of Maryland, Baltimore, MD 20742, USA","institution_ids":["https://openalex.org/I126744593"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108461895","display_name":"Vinod P. Shah","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Vinod P. Shah","raw_affiliation_strings":["Pharmaceutical Consultant, North Potomac, MD, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pharmaceutical Consultant, North Potomac, MD, USA","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5076946026","display_name":"Jennifer Dressman","orcid":"https://orcid.org/0000-0001-9066-3980","observed_orcids":["https://orcid.org/0000-0001-9066-3980","https://orcid.org/0009-0006-0148-9225"]},"institutions":[{"id":"https://openalex.org/I4210107844","display_name":"Fraunhofer Institute for Translational Medicine and Pharmacology","ror":"https://ror.org/01s1h3j07","country_code":"DE","type":"facility","lineage":["https://openalex.org/I4210107844","https://openalex.org/I4923324"]}],"countries":["DE"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Jennifer Dressman","raw_affiliation_strings":["Fraunhofer Institute for Translational Medicine and Pharmacology, Frankfurt am Main, Germany. Electronic address: Dressman@em.uni-frankfurt.de"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Fraunhofer Institute for Translational Medicine and Pharmacology, Frankfurt am Main, Germany. Electronic address: Dressman@em.uni-frankfurt.de","institution_ids":["https://openalex.org/I4210107844"]}]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":7,"corresponding_author_ids":["https://openalex.org/A5076946026"],"corresponding_institution_ids":["https://openalex.org/I4210107844"],"apc_list":{"value":3620,"currency":"USD","value_usd":3620},"apc_paid":null,"fwci":0.3322,"has_fulltext":true,"cited_by_count":11,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.2738255,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":92,"max":98},"biblio":{"volume":"114","issue":"2","first_page":"660","last_page":"680"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10256","display_name":"Drug Solubulity and Delivery Systems","score":0.9810000061988831,"subfield":{"id":"https://openalex.org/subfields/3003","display_name":"Pharmaceutical Science"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12547","display_name":"Pharmaceutical studies and practices","score":0.006099999882280827,"subfield":{"id":"https://openalex.org/subfields/2735","display_name":"Pediatrics, Perinatology and Child Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11460","display_name":"Analytical Methods in Pharmaceuticals","score":0.002899999963119626,"subfield":{"id":"https://openalex.org/subfields/1602","display_name":"Analytical Chemistry"},"field":{"id":"https://openalex.org/fields/16","display_name":"Chemistry"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/voriconazole","display_name":"voriconazole","score":0.9990000128746033},{"id":"https://openalex.org/keywords/biowaiver","display_name":"biowaiver","score":0.9240000247955322},{"id":"https://openalex.org/keywords/biopharmaceutics-classification-system","display_name":"Biopharmaceutics Classification System","score":0.9359999895095825},{"id":"https://openalex.org/keywords/bcs-class-ii","display_name":"BCS class II","score":0.8679999709129333},{"id":"https://openalex.org/keywords/solubility","display_name":"solubility","score":0.7170000076293945},{"id":"https://openalex.org/keywords/biorelevant-dissolution-testing","display_name":"biorelevant dissolution testing","score":0.6769999861717224},{"id":"https://openalex.org/keywords/bioequivalence","display_name":"bioequivalence","score":0.8050000071525574},{"id":"https://openalex.org/keywords/antifungal-agents","display_name":"antifungal agents","score":0.7149999737739563},{"id":"https://openalex.org/keywords/immediate-release-tablets","display_name":"immediate release tablets","score":0.6430000066757202}],"concepts":[{"id":"https://openalex.org/C2780690907","wikidata":"https://www.wikidata.org/wiki/Q412236","display_name":"Voriconazole","level":3,"score":0.9192402362823486},{"id":"https://openalex.org/C2781430271","wikidata":"https://www.wikidata.org/wiki/Q278760","display_name":"Biopharmaceutics Classification System","level":3,"score":0.705931544303894},{"id":"https://openalex.org/C2910701995","wikidata":"https://www.wikidata.org/wiki/Q679692","display_name":"Biopharmaceutics","level":5,"score":0.686134934425354},{"id":"https://openalex.org/C42404028","wikidata":"https://www.wikidata.org/wiki/Q864940","display_name":"Bioequivalence","level":3,"score":0.612727701663971},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.5567220449447632},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5390002727508545},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5144234299659729},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4967098832130432},{"id":"https://openalex.org/C2780182762","wikidata":"https://www.wikidata.org/wiki/Q1630279","display_name":"Guideline","level":2,"score":0.47863808274269104},{"id":"https://openalex.org/C2779548794","wikidata":"https://www.wikidata.org/wiki/Q578726","display_name":"Antifungal","level":2,"score":0.40081465244293213},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.27315080165863037},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.13898229598999023},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.10169783234596252},{"id":"https://openalex.org/C160492267","wikidata":"https://www.wikidata.org/wiki/Q319616","display_name":"Pharmacognosy","level":4,"score":0.07727265357971191},{"id":"https://openalex.org/C116073593","wikidata":"https://www.wikidata.org/wiki/Q864491","display_name":"Biological activity","level":3,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000284","descriptor_name":"Administration, Oral","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000935","descriptor_name":"Antifungal Agents","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D001702","descriptor_name":"Biopharmaceutics","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012995","descriptor_name":"Solubility","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013607","descriptor_name":"Tablets","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065546","descriptor_name":"Drug Liberation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065819","descriptor_name":"Voriconazole","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D065819","descriptor_name":"Voriconazole","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D065819","descriptor_name":"Voriconazole","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true}],"locations_count":4,"locations":[{"id":"doi:10.1016/j.xphs.2024.10.055","doi":"https://doi.org/10.1016/j.xphs.2024.10.055","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.xphs.2024.10.055","pdf_url":"https://jpharmsci.org/article/S0022-3549(24)00504-5/pdf","source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},{"id":"pmid:39547650","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/39547650","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of pharmaceutical sciences","raw_type":"Journal Article"},{"id":"pmh:oai:sdu.dk:openaire_cris_publications/242115f9-ab22-4246-a899-dbc67cb40934","doi":null,"is_oa":false,"landing_page_url":"https://portal.findresearcher.sdu.dk/da/publications/242115f9-ab22-4246-a899-dbc67cb40934","pdf_url":null,"source":{"id":"https://openalex.org/S4306400423","display_name":"University of Southern Denmark Research Portal (University of Southern Denmark)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I177969490","host_organization_name":"University of Southern Denmark","host_organization_lineage":["https://openalex.org/I177969490"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Beran, K, Abrahamsson, B, Charoo, N, Cristofoletti, R, Holm, R, Kambayashi, A, Langguth, P, Parr, A, Polli, J E, Shah, V P & Dressman, J 2025, 'Biowaiver monographs for immediate-release solid oral dosage forms : Voriconazole', Journal of Pharmaceutical Sciences, vol. 114, no. 2, pp. 660-680. https://doi.org/10.1016/j.xphs.2024.10.055","raw_type":"info:eu-repo/semantics/article"},{"id":"pmh:oai:publica.fraunhofer.de:publica/512170","doi":null,"is_oa":false,"landing_page_url":"https://publica.fraunhofer.de/handle/publica/512170","pdf_url":null,"source":{"id":"https://openalex.org/S4306400318","display_name":"Fraunhofer-Publica (Fraunhofer-Gesellschaft)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4923324","host_organization_name":"Fraunhofer-Gesellschaft","host_organization_lineage":["https://openalex.org/I4923324"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"note"}],"best_oa_location":{"id":"doi:10.1016/j.xphs.2024.10.055","doi":"https://doi.org/10.1016/j.xphs.2024.10.055","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.xphs.2024.10.055","pdf_url":"https://jpharmsci.org/article/S0022-3549(24)00504-5/pdf","source":{"id":"https://openalex.org/S130661733","display_name":"Journal of Pharmaceutical Sciences","issn_l":"0022-3549","issn":["0022-3549","1520-6017"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Pharmaceutical Sciences","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.6240000128746033,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G434337789","display_name":null,"funder_award_id":"HORIZON2020","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G5241279497","display_name":"A fully integrated, animal-free, end-to-end modelling approach to oral drug product development","funder_award_id":"955756","funder_id":"https://openalex.org/F4320320300","funder_display_name":"European Commission"},{"id":"https://openalex.org/G5322214677","display_name":"A fully integrated, animal-free, end-to-end modelling approach to oral drug product development","funder_award_id":"955756","funder_id":"https://openalex.org/F4320338337","funder_display_name":"H2020 Marie Sk\u0142odowska-Curie Actions"}],"funders":[{"id":"https://openalex.org/F4320320300","display_name":"European Commission","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320332999","display_name":"Horizon 2020 Framework Programme","ror":"https://ror.org/00k4n6c32"},{"id":"https://openalex.org/F4320338337","display_name":"H2020 Marie Sk\u0142odowska-Curie Actions","ror":null}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4404356876.pdf","grobid_xml":"https://content.openalex.org/works/W4404356876.grobid-xml"},"referenced_works_count":58,"referenced_works":["https://openalex.org/W94359709","https://openalex.org/W572885427","https://openalex.org/W1499768710","https://openalex.org/W1522767714","https://openalex.org/W1563224671","https://openalex.org/W1830468797","https://openalex.org/W1967601691","https://openalex.org/W1985282417","https://openalex.org/W1987910942","https://openalex.org/W2010487775","https://openalex.org/W2016465981","https://openalex.org/W2024277077","https://openalex.org/W2035069664","https://openalex.org/W2036323185","https://openalex.org/W2055076524","https://openalex.org/W2057200506","https://openalex.org/W2058668950","https://openalex.org/W2081308723","https://openalex.org/W2094884101","https://openalex.org/W2097777738","https://openalex.org/W2101089712","https://openalex.org/W2101785863","https://openalex.org/W2103424986","https://openalex.org/W2105286149","https://openalex.org/W2105376278","https://openalex.org/W2106444474","https://openalex.org/W2107905362","https://openalex.org/W2126617328","https://openalex.org/W2129827408","https://openalex.org/W2130666684","https://openalex.org/W2146368414","https://openalex.org/W2150428940","https://openalex.org/W2151423002","https://openalex.org/W2164239173","https://openalex.org/W2291667458","https://openalex.org/W2318356430","https://openalex.org/W2375718461","https://openalex.org/W2400119402","https://openalex.org/W2470291098","https://openalex.org/W2514632012","https://openalex.org/W2528269894","https://openalex.org/W2552852190","https://openalex.org/W2756221400","https://openalex.org/W2796455913","https://openalex.org/W2797508402","https://openalex.org/W2898682016","https://openalex.org/W2914041138","https://openalex.org/W2953189690","https://openalex.org/W2975748700","https://openalex.org/W3012204095","https://openalex.org/W3120329100","https://openalex.org/W3202290265","https://openalex.org/W4312143513","https://openalex.org/W4383820165","https://openalex.org/W4388574581","https://openalex.org/W4399904095","https://openalex.org/W4403150741","https://openalex.org/W4403680546"],"related_works":["https://openalex.org/W2146368414","https://openalex.org/W4388574581","https://openalex.org/W4416943638","https://openalex.org/W1937861928","https://openalex.org/W2995012576","https://openalex.org/W1970728958","https://openalex.org/W7221160108","https://openalex.org/W3005276216","https://openalex.org/W3214602206","https://openalex.org/W4391071612"],"abstract_inverted_index":null,"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4404356876","counts_by_year":[{"year":2026,"cited_by_count":5},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":2}],"updated_date":"2026-11-18T13:11:19.462570","created_date":"2024-11-15T00:00:00"}
